Aberrant DNA methylation in ulcerative colitis without neoplasia

Fang Yu Wang, Tomiyasu Arisawa, Tomomitsu Tahara, Kazuya Takahama, Makoto Watanabe, Ichiro Hirata, Hiroshi Nakano

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)


Background/Aims: DNA methylation has been reported to correlate with the development of colitis associated cancer. We detected the promoter methylation of estrogen receptor gene (ER), TP53, p14, p16, p21 and hMLH1 in ulcerative colitis without neoplasia. Methodology: A total of 49 specimens from 36 patients, including 36 at rectal inflammatory mucosa and 13 at terminal ileum were obtained by colonoscopic biopsies. Methylation specific polymerase chain reaction were performed to detect the methylation in promoters of the above six genes. Results: Methylation rate of ER promoter was significantly higher in the rectal mucosa than that in the ileum (76.3% vs. 46.2%, P=0.044). Moreover, ER methylation in rectal mucosa was significantly higher in relapse-remitting type compared to one attack only type cases (P=0.008), and also increased in cases longer than 7 years (P=0.036). Methylation rates of p14 or p16 were higher in rectal mucosa than those in the ileum, but the differences were not of statistic significance. Meanwhile, methylation in TP53 promoter was found in only one case, while p21 and hMLH1 methylation were negative in all cases. Conclusions: Methylation in promoters of ER, p14 and p16 occurs in rectal inflammatory mucosa without neoplasia. Examination of ER methylation in rectal mucosa may be useful for predicting cases at high risk of neoplasia.

Original languageEnglish
Pages (from-to)62-65
Number of pages4
Issue number81
Publication statusPublished - 01-2008
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Aberrant DNA methylation in ulcerative colitis without neoplasia'. Together they form a unique fingerprint.

Cite this